Literature DB >> 14965295

The design of screening libraries targeted at G-protein coupled receptors.

Roger Crossley1.   

Abstract

The screening of large libraries in order to obtain hits for receptors of interest has been the mainstay of drug research for some time now. It is increasingly being recognised that this is a relatively inefficient way to achieve this end and the screening of libraries either designed or selected to hit particular targets is rapidly becoming the method of choice. The advantages in terms of success rate to achieve viable lead series are magnified by the cost and time savings achieved by screening more carefully selected groups of compounds. A number of approaches have been used for the design and production of such libraries or methods for selection of such focused sets from larger diverse collections. These range from combinatorially produced ligand-mimetic approaches through pharmacophore-based design to those methods based on statistical selection techniques. Most recently, progress in chemogenomic approaches has thrown new light on the relationship between receptor sequence and compounds that interact at particular receptors and this is also having an impact on the design of targeted libraries.

Mesh:

Substances:

Year:  2004        PMID: 14965295     DOI: 10.2174/1568026043451140

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  3 in total

Review 1.  Chemogenomic approaches to rational drug design.

Authors:  D Rognan
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

2.  A system for screening agonists targeting beta2-adrenoceptor from Chinese medicinal herbs.

Authors:  Hui Wang; Shi-you Li; Chuan-ke Zhao; Xin Zeng
Journal:  J Zhejiang Univ Sci B       Date:  2009-04       Impact factor: 3.066

3.  Chemical Probe Identification Platform for Orphan GPCRs Using Focused Compound Screening: GPR39 as a Case Example.

Authors:  Markus Boehm; David Hepworth; Paula M Loria; Lisa D Norquay; Kevin J Filipski; Janice E Chin; Kimberly O Cameron; Martin Brenner; Peter Bonnette; Shawn Cabral; Edward Conn; David C Ebner; Denise Gautreau; John Hadcock; Esther C Y Lee; Alan M Mathiowetz; Michelle Morin; Lucy Rogers; Aaron Smith; Maria VanVolkenburg; Philip A Carpino
Journal:  ACS Med Chem Lett       Date:  2013-09-16       Impact factor: 4.345

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.